Literature DB >> 3957986

Treatment of idiopathic scoliosis with the Wilmington brace. Results in patients with a twenty to thirty-nine-degree curve.

G S Bassett, W P Bunnell, G D MacEwen.   

Abstract

The results in seventy-nine adolescent patients (ninety-five curves) who had idiopathic scoliosis treated with the Wilmington brace are reported. The average follow-up was two years and six months (range, one to nine years). Before treatment, all of the patients had a curve that measured 20 to 39 degrees and a Risser sign of zero or 1. Although the magnitude of the curve was generally reduced by about 50 per cent with the initial application of the brace, a gradual loss of this initial improvement was observed both during active treatment and after the patient was weaned from the brace. Although twenty-seven (28 per cent) of the curves had progressed more than 5 degrees at follow-up, Lonstein and Carlson reported that the projected probability of progression of untreated 20 to 29-degree curves is 68 per cent. Thirty-six per cent of the thoracic curves, 16 per cent of the thoracolumbar and lumbar curves, and 28 per cent of the double major curves had progression of more than 5 degrees. However, only 11 per cent of the patients had a curve that progressed sufficiently to warrant fusion. Our findings indicate that the Wilmington brace favorably alters the natural history of 20 to 39-degree idiopathic curves.

Entities:  

Mesh:

Year:  1986        PMID: 3957986

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

1.  Design of the Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST).

Authors:  Stuart L Weinstein; Lori A Dolan; James G Wright; Matthew B Dobbs
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-01       Impact factor: 3.468

2.  [Compliance as a prognostic factor in the treatment of idiopathic scoliosis].

Authors:  J Seifert; A Selle; C Flieger; K P Günther
Journal:  Orthopade       Date:  2009-02       Impact factor: 1.087

3.  Brace technology thematic series: the progressive action short brace (PASB).

Authors:  Francesco Falciglia; Marco Giordano; Emanuele Marzetti; Vincenzo Guzzanti; Angelo G Aulisa; Giuseppe Mastantuoni; Marco Laineri
Journal:  Scoliosis       Date:  2012-02-23

4.  Electronic monitoring of scoliosis brace wear compliance.

Authors:  Tariq Rahman; Battugs Borkhuu; Aaron G Littleton; Whitney Sample; Ed Moran; Stephen Campbell; Kenneth Rogers; J Richard Bowen
Journal:  J Child Orthop       Date:  2010-06-03       Impact factor: 1.548

5.  Results of brace treatment of adolescent idiopathic scoliosis in boys compared with girls: a retrospective study of 102 patients treated with the Boston brace.

Authors:  Timo Yrjönen; Mauno Ylikoski; Dietrich Schlenzka; Mikko Poussa
Journal:  Eur Spine J       Date:  2006-08-15       Impact factor: 3.134

Review 6.  Brace management in adolescent idiopathic scoliosis.

Authors:  Jonathan R Schiller; Nikhil A Thakur; Craig P Eberson
Journal:  Clin Orthop Relat Res       Date:  2009-05-30       Impact factor: 4.176

7.  Brace technology thematic series - The Sforzesco and Sibilla braces, and the SPoRT (Symmetric, Patient oriented, Rigid, Three-dimensional, active) concept.

Authors:  Stefano Negrini; Gianfranco Marchini; Fabrizio Tessadri
Journal:  Scoliosis       Date:  2011-05-09

Review 8.  Optimal management of idiopathic scoliosis in adolescence.

Authors:  Tomasz Kotwicki; Joanna Chowanska; Edyta Kinel; Dariusz Czaprowski; Marek Tomaszewski; Piotr Janusz
Journal:  Adolesc Health Med Ther       Date:  2013-07-23

9.  Electronic monitoring of orthopedic brace compliance.

Authors:  Tariq Rahman; Whitney Sample; Petya Yorgova; Geraldine Neiss; Kenneth Rogers; Suken Shah; Peter Gabos; Dan Kritzer; J Richard Bowen
Journal:  J Child Orthop       Date:  2015-08-28       Impact factor: 1.548

10.  Clinical effect of continuous corrective force delivery in the non-operative treatment of idiopathic scoliosis: a prospective cohort study of the TriaC-brace.

Authors:  Gerben J Bulthuis; Albert G Veldhuizen; Gert Nijenbanning
Journal:  Eur Spine J       Date:  2007-10-10       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.